Tune in to this recording from a live symposium offered in conjunction with the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers 2025 symposium, where two leading upper GI cancer experts delve into the latest advances in the management of gastric, gastroesophageal junction, and esophageal cancers. Explore insights into novel therapeutic targets, alongside the latest biomarker testing guidelines and best practices for guiding treatment decisions. Gain a deeper understanding of the mechanisms of action behind novel therapies through discussions and an engaging 2D video animation, and discover the latest clinical data for these treatments. Hear a discussion with the expert panel exploring how team-based approaches and multidisciplinary strategies can optimize biomarker testing, individualize treatment selection, and improve the management of adverse events. Don’t miss this unique opportunity to stay ahead of the rapidly evolving therapeutic landscape in upper GI cancers, and enhance your ability to deliver evidence-based, multidisciplinary care to your patients.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/precision-progress-targeting-future-upper-gi-cancers-live-national-symposium
- Start Date: 2025-02-21 06:00:00
- End Date: 2025-02-21 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Astellas (Any division) - Amount: 37500.0 - Is Kind Support: False Source: Gilead Sciences, Inc. - Amount: 62750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all